Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
AST-006 by Ascentawits Pharmaceuticals for Ovarian Cancer: Likelihood of Approval
AST-006 is under clinical development by Ascentawits Pharmaceuticals and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase...
Data Insights
AST-006 by Ascentawits Pharmaceuticals for Breast Cancer: Likelihood of Approval
AST-006 is under clinical development by Ascentawits Pharmaceuticals and currently in Phase I for Breast Cancer. According to GlobalData, Phase...